Crow Point Partners’s Elevance Health ELV Stock Holding History

Crow Point Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$519K	Buy	3,707 +40	+1%	+$6.01K	0.08%	101
2015 Q2	$602K	Buy	3,667 +117	+3%	+$18.7K	0.09%	101
2015 Q1	$548K	Buy	+3,550	New	+$505K	0.07%	106
2014 Q3	$663K	Buy	5,540 +30	+0.5%	+$3.44K	0.09%	113
2014 Q2	$549K	Hold	5,510	–	–	0.07%	118
2014 Q1	$549K	Buy	+5,510	New	+$498K	0.07%	118

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Crow Point Partners's ELV Position: Q3 2015 in Review

Crow Point Partners increased its Elevance Health (ELV) stake by 1.1% in Q3 2015, buying an estimated $6.01K and bringing the position to 3,707 shares worth $519K. The position accounts for 0.08% of the portfolio, ranked #101.

Crow Point Partners first reported a position in ELV in Q1 2014 and has held it in 6 quarters since. The position peaked at $663K in Q3 2014. 762 funds tracked by Wall St. Rank hold ELV as of Q3 2015.

Crow Point Partners held 3,707 shares of Elevance Health worth $519K as of Q3 2015.
Crow Point Partners bought 40 Elevance Health shares in Q3 2015, an estimated $6.01K.
Elevance Health made up 0.08% of Crow Point Partners's portfolio in Q3 2015, its #101 holding.
Crow Point Partners first reported a position in Elevance Health in Q1 2014 and has held it in 6 quarters since.
Crow Point Partners's Elevance Health position peaked at $663K in Q3 2014.
762 funds tracked by Wall St. Rank held Elevance Health as of Q3 2015.

Based on Crow Point Partners's 13F filing for Q3 2015, filed 17 Dec 2015.